This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Mr. Azriel is a seasoned lawyer with wide-ranging expertise in management and optimization of large-scale organizations. He served as the General Manager of the National Insurance Institute
of Israel (NII), was a partner in Glass, Feinstein and Azriel law firm, the owner of his own law firm, and the head of the municipality of Mevaseret Tzion.
As head of the NII, he installed and implemented a variety of bills as well as the tax collection system and a reform in the administrational system.
As the head of a municipality, he led a complex reform and promoted plans for large industrial zones and residential areas.
He also served as a director in public and private companies.
Mr. Azriel earned an LLB degree from the Hebrew University in Jerusalem.